Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Matthew D. Barber, MD, MHS, is Professor of Surgery at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University and Vice-Chair of Clinical Research in the OB/Gyn and Women's Health Institute. He is a Staff Physician in the Section of Urogynecology and Pelvic Reconstructive Surgery in the Department of Ob/Gyn and the Glickman Urological Institute at Cleveland Clinic. He is Board-certified in Obstetrics/Gynecology and Female Pelvic Medicine and Reconstructive Surgery
Dr. Barber was President of the American Urogynecologic Society (AUGS) from 2011-2012 and was named the 2009 Continence Care Champion by the National Association for Continence (NAFC). He is currently the Chair of the Steering Committee of the Pelvic Floor Disorders Registry, a national registry of surgery for pelvic organ prolapse. He is a Scientific Editor for the British Journal of Obstetrics & Gynecology (BJOG), a Section Editor for the journal Female Pelvic Medicine and Reconstructive Surgery and on the Editorial Board of the International Urogynecology Journal.
Prior to joining Cleveland Clinic in 2001, he was an associate in the Department of Obstetrics and Gynecology at Duke University Medical Center in Durham, North Carolina. He is a fellow of the American College of Obstetrics and Gynecology and a diplomate of the American Board of Obstetrics and Gynecology.
Dr. Barber's specialty interests include pelvic organ prolapse, urinary incontinence, fecal incontinence, vesicovaginal, rectovaginal fistulas and management of pelvic mesh complications
Dr. Barber received his medical degree from Thomas Jefferson Medical College in Philadelphia, Pennsylvania, where he graduated summa cum laude. He then went on to Duke University, where he earned a Master of Health Sciences degree in Clinical Research and completed a residency in obstetrics and gynecology, as well as a fellowship in urogynecology and pelvic reconstructive surgery. He is licensed to practice medicine in Ohio and North Carolina. He has been listed on the Top Doctor's list in 2010 and 2011
He is lead or co-author on over 160 research studies published in peer-reviewed publications or presented at leading medical conferences in his field. He is also author or co-author of many chapters in medical textbooks, and he regularly gives presentations and seminars. Dr. Barber has won numerous academic awards and research grants, including, to name only a few, the National Faculty Award from the American College of Obstetrics and Gynecology & The Council on Resident Education in Obstetrics and Gynecology (2005), Teacher of the Year in Obstetrics and Gynecology at Cleveland Clinic (2002 – 03 and 2004 – 05) the Society for Gynecologic Surgeons Prize Paper (2008), and American Urogynecologic Society Best Clinical/Surgical Paper (2011 and 2013)
Urogynecology and Pelvic Reconstructive Surgery, Pelvic Organ Prolapse, Urinary Incontinence, Fecal Incontinence, Vesicovaginal and rectovaginal fistulas, pelvic reconstructive surgery, vaginal mesh complications
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/13/2014, Dr. Barber has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.